| Name | tepraloxydim |
|---|---|
| Synonyms |
2-[1-[[(E)-3-chloroprop-2-enoxy]amino]propylidene]-5-(oxan-4-yl)cyclohexane-1,3-dione
rac-(5R)-2-[(1Ξ)-N-{[(2E)-3-chloroprop-2-en-1-yl]oxy}propanimidoyl]-3-hydroxy-5-(oxan-4-yl)cyclohex-2-en-1-one Tepraloxydim (5RS)-2-{(EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one 2-Cyclohexen-1-one, 2-[(1E)-1-[[[(2E)-3-chloro-2-propen-1-yl]oxy]imino]propyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)- (EZ)-(RS)-2-{1-[(2E)-3-Chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one 2-[(1E)-N-{[(2E)-3-Chloroprop-2-en-1-yl]oxy}propanimidoyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)cyclohex-2-en-1-one 2-[(1E)-N-{[(2E)-3-Chlorprop-2-en-1-yl]oxy}propanimidoyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)cyclohex-2-en-1-on T6OTJ D- EL6V BUTJ BY2&UNO2U1G CQ &&E Form UNII:8QHN14BQ7F 2-[1-[[[(2E)-3-chloro-2-propen-1-yl]oxy]imino]propyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)-2-cyclohexen-1-one 2-[(1E)-N-{[(2E)-3-Chloro-2-propen-1-yl]oxy}propanimidoyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)-2-cyclohexen-1-one teproloxydim |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 469.1±55.0 °C at 760 mmHg |
| Melting Point | 71.5° |
| Molecular Formula | C17H24ClNO4 |
| Molecular Weight | 341.830 |
| Flash Point | 237.5±31.5 °C |
| Exact Mass | 341.139374 |
| PSA | 68.12000 |
| LogP | 2.88 |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.564 |
| Storage condition | 0-6°C |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H351-H361 |
| Precautionary Statements | P281 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn,N |
| Risk Phrases | R61 |
| Safety Phrases | S53 |
| RIDADR | NONH for all modes of transport |